FDA Warns API Labeler for Lacking Basic Quality Controls

Drug GMP Report

Mar. 04, 2014

The FDA has warned China’s CBSCHEM Limited, an active pharmaceutical ingredient (API) labeler, for ignoring fundamental quality functions such as keeping detailed records and maintaining a quality unit.
Read More